Cytokeratin 18 Monoclonal Antibody(1B3)

KRT18 encodes the type I intermediate filament chain keratin 18. Keratin 18, together with its filament partner keratin 8, are perhaps the most commonly found members of the intermediate filament gene family. They are expressed in single layer epithelial tissues of the body. Mutations in this gene have been linked to cryptogenic cirrhosis. Two transcript variants encoding the same protein have been found for this gene.

The CYTOKERATIN 18 MONOCLONAL ANTIBODY(1B3) is a highly specialized and meticulously developed product that serves as an invaluable tool in various scientific and medical applications. This monoclonal antibody, specifically designed to target Cytokeratin 18, offers exceptional specificity and sensitivity, making it an ideal choice for researchers and clinicians alike.

With its advanced technology and rigorous quality control measures, this antibody ensures reliable and reproducible results, enabling accurate and precise analysis. Its exceptional binding affinity to Cytokeratin 18 guarantees optimal performance in immunohistochemistry, immunofluorescence, and other related techniques.

The CYTOKERATIN 18 MONOCLONAL ANTIBODY(1B3) exhibits exceptional versatility, allowing for its utilization in a wide range of research areas, including cancer biology, cell biology, and tissue engineering. Its ability to specifically detect Cytokeratin 18, a protein commonly expressed in epithelial cells, enables the identification and characterization of various cell types and tissues.

Furthermore, this antibody's compatibility with multiple sample types, such as formalin-fixed paraffin-embedded tissues and cell cultures, enhances its applicability in diverse experimental settings. Its robust performance in both routine and challenging experimental conditions ensures consistent and accurate results, facilitating meaningful scientific discoveries and clinical diagnoses.

The CYTOKERATIN 18 MONOCLONAL ANTIBODY(1B3) is manufactured under stringent quality control standards, ensuring its reliability, reproducibility, and consistency. Each batch undergoes rigorous testing to guarantee its specificity, sensitivity, and stability, providing researchers and clinicians with a dependable tool for their investigations.

In summary, the CYTOKERATIN 18 MONOCLONAL ANTIBODY(1B3) is a highly specialized and meticulously developed product that offers exceptional specificity, sensitivity, and versatility. Its advanced technology, compatibility with various sample types, and robust performance make it an indispensable tool for researchers and clinicians in their pursuit of scientific advancements and improved patient care.